1. Professional bodies, the pharmaceutical industry, and commercial sponsorship

   • N. J. C. Snell

   Commentary 24 August 2012 Pages: 161 - 165

2. Safety Assessment of Marketed Medicines (SAMM) studies: problems addressed but problems raised?

   • Jon G. Ayres
   • Chris Frost
   • Susan M. Ward

   Commentary 24 August 2012 Pages: 167 - 169

   

3. New FDA Commissioner appointed

   News 24 August 2012 Pages: 171 - 171

4. A safety evaluation of an extrafine aerosol of beclomethasone dipropionate in 6161 patients using the UK SAMM guidelines

   • Jon G. Ayres
   • Chris Frost
   • Susan M. Ward

   Original Article 24 August 2012 Pages: 173 - 178

   

5. Analysis of 312 studies of investigational medicinal products in healthy subjects to assess the impact of the European Union Clinical Trials Directive

   • Malcolm Boyce
   • Steve Warrington

   Original Article 24 August 2012 Pages: 179 - 183

   

6. News from member associations

   • Luis Collia
   • Herman Lahon
   • Patricia Byrns

   IFAPP News 24 August 2012 Pages: 185 - 185

   

7. Letter from Dr Domenico Criscuolo, President of IFAPP

   • Domenico Criscuolo

   IFAPP News 24 August 2012 Pages: 185 - 191

8. Other news from AAPP

   • Chris Allen

   IFAPP News 24 August 2012 Pages: 191 - 191

9. 12th International Conference on Pharmaceutical Medicine, Cancun, Mexico, 5–8 May 2002

   • Jorge Paquentin
   • German Novoa
   • Peter Stonier

   IFAPP News 24 August 2012 Pages: 192 - 193

10. Future Meetings

    Society of Pharmaceutical Medicine 24 August 2012 Pages: 195 - 195

11. Calendar of events

    Events 24 August 2012 Pages: 197 - 197

    

12. Workplace

    OriginalPaper 24 August 2012 Pages: 199 - 202